Clinical Trials Directory

Trials / Unknown

UnknownNCT03187652

A Prospective Study on the Long-Term Vascular Burden in Thrombotic Thrombocytopenic Purpura Patients

Status
Unknown
Phase
Study type
Observational
Enrollment
35 (estimated)
Sponsor
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

A prospective cohort study of thrombotic thrombocytopenic purpura and atypical hemolytic uremic syndrome patients who have presented with their acute episode and are in remission within the last 30 days. They will be followed for 12 months from the time of their initial scan, followed by a long-term follow up study.

Detailed description

The investigators will conduct a prospective cohort study at the London Health Sciences Centre, Ontario, Canada. The investigators will identify 15-30 idiopathic thrombotic thrombocytopenic purpura and atypical hemolytic uremic syndrome patients who are in remission within the last 30 days. They will be followed for 12 months from the time of their remission. Study procedures include routine laboratory monitoring, biomarker assessments, cardiovascular and neurocognitive functional assessments, and non-invasive imaging studies. The long-term follow-up thrombotic thrombocytopenic purpura and atypical hemolytic uremic syndrome study will help to assess the mechanisms of vascular injuries, evaluate cardiovascular and cerebrovascular monitoring tools, and generate novel ideas to prevent further vascular injuries.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTCT Perfusion StudyBrain and cardiac CT perfusion scan
DIAGNOSTIC_TESTEchocardiogramSpeckle tracking Echocardiography
DIAGNOSTIC_TESTneuro-cognitive assessmentCambridge Brain Sciences neuro-cognitive assessment
DIAGNOSTIC_TESTMRIMRI to assess white matter changes

Timeline

Start date
2017-01-01
Primary completion
2026-01-01
Completion
2026-01-01
First posted
2017-06-15
Last updated
2024-03-13

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT03187652. Inclusion in this directory is not an endorsement.